Treatment of coronavirus infection with Flt3 receptor interacting lectin (FRIL)
AssigneeAcademia Sinica
InventorsChe Ma, Jia-Tsrong Jan
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a method for treating or preventing a coronavirus infection, which comprises administering to a subject in need thereof an effective amount of a composition comprising Flt3 receptor interacting lectin (FRIL) from Lablab purpureus. Also disclosed is a pharmaceutical composition comprising a pharmaceutically acceptable excipient, a Lablab purpureus FRIL, and an additional therapeutic agent.
Claims13
A method for treating a coronavirus infection, comprising administering to a subject in need thereof an effective amount of a composition comprising Flt3 receptor interacting lectin (FRIL) from Lablab purpureus, wherein the FRIL comprises SEQ ID NO:
- 1.
Dependencies are inferred from the claim text.